Harel Insurance Investments & Financial Services’s CollPlant Biotechnologies CLGN Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-106	Closed	-$1K	–	453
2019 Q4	$1K	Hold	106	–	–	﹤0.01%	459
2019 Q3	$0	Buy	+106	New	+$426	﹤0.01%	503
2019 Q2	–	Sell	-106	Closed	-$1K	–	474
2019 Q1	$1K	Sell	106 -4,000	-97%	-$21.4K	﹤0.01%	439
2018 Q4	$17K	Buy	+4,106	New	+$21.4K	﹤0.01%	393

Other funds holding CLGN

IMOV

Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Harel Insurance Investments & Financial Services's CLGN Position: Q1 2020 in Review

Harel Insurance Investments & Financial Services sold out of CollPlant Biotechnologies (CLGN) in Q1 2020, closing a stake of 106 shares — an estimated $1K sold.

Harel Insurance Investments & Financial Services first reported a position in CLGN in Q4 2018 and held it in 4 quarters. The position peaked at $17K in Q4 2018. 4 funds tracked by Wall St. Rank hold CLGN as of Q1 2020.

Harel Insurance Investments & Financial Services reported no remaining CollPlant Biotechnologies position as of Q1 2020 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 106 CollPlant Biotechnologies shares in Q1 2020, an estimated $1K.
Harel Insurance Investments & Financial Services first reported a position in CollPlant Biotechnologies in Q4 2018 and held it in 4 quarters.
Harel Insurance Investments & Financial Services's CollPlant Biotechnologies position peaked at $17K in Q4 2018.
4 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2020.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2020, filed 28 Apr 2020.